Udia Poll

What is the most pressing industry issue facing the new NSW Government?

UDIA NSW event

Professional Development

Non UDIA event

Thu
29
Nov

Annual Christmas Luncheon

Venue:
Four Seasons Hotel, Grand Ballroom, 199 George St, Sydney
Time:
12:00 PM - 2:30 PM
Date:
Thursday 29 Nov 2018
RSVP Date:
Monday 26 Nov 2018
Price per individual:
$190 - Member
$240 - Non Member
Price per table (10 people):
$1800 - Member
$2300 - Non Member


Event details 

Celebrate the start of the festive season at our Annual Christmas Luncheon. Network with your industry colleagues over a two-course lunch and beverages as we look back on the year that was. We will also be fundraising for the Foundation for Angelman Syndrome Therapeutics Australia. 
 
Joining us this year is Alison Frame, Deputy Secretary of NSW Department of Planning & Environment. Alison will provide some cheer highlighting the key focus for the Department into the new year.  
 
The renewed focus on strategic planning and IHAPs are welcome helping our industry drive supply, growth, and affordability in NSW. However, challenges remain for infrastructure  funding, new taxes and the suspension of the missing middle. The agenda for next year is already looking good with new strategic planning statements, drafting LEPs, community participation plans, and a standardised DCP.
 
This event is a sell-out each year, book early to secure your space.

 

Guest speaker

Alison Frame, Deputy Secretary, NSW Department of Planning and Environment
 
 

Major sponsor

 

After party sponsor

 

UDIA NSW proudly supports


Angelman syndrome (AS) is a rare neurogenetic disorder that affects approximately one in 15,000 people – about 500,000 individuals worldwide. Children and adults with AS typically have balance issues, motor impairment and debilitating seizures. Some individuals never walk. Most do not speak. Disrupted sleep cycles also can be a serious challenge to the individual and caregivers(s). Individuals with AS require continuous care and are unable to live independently. They have a normal life expectancy. Life is very challenging for people with Angelman Syndrome today, however hope is here. Scientists believe that AS has the greatest potential for being cured when compared to other neurogenetic disorders.

 
FAST (Foundation for Angelman Syndrome Therapeutics) has a plan well underway to achieve a cure for those individuals. FAST is working closely with scientists and leading the way to achieving positive results by ensuring that all possible avenues for treatment and a potential cure is being explored. 
 
The FAST board consists of a number of Parents of children with Angelman syndrome, with 95% of all money raised and donated, directed at funding research into a treatement and a cure.
 


Contact us

Phone: 02 9262 1214